Chemical Compound

4'-Epidoxorubicin hydrochloride; 4'-epi-Adriamycin hydrochloride; Ellence; Epidoxorubicin hydrochloride; Epirubicin hydrochloride; Farmorubicin; Pharmorubicin; (8S,10S)-10-[(3-Amino-2,3,6-trideoxy-alpha-l-arabino-hexopyranosyl)oxy]-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride; 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-, hydrochloride (1:1), (8S,10S)-; 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S,10S)- (9CI); 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)-

CAS Registry Number 56390-09-1
返回搜索 申请报价
4'-Epidoxorubicin hydrochloride; 4'-epi-Adriamycin hydrochloride; Ellence; Epidoxorubicin hydrochloride; Epirubicin hydrochloride; Farmorubicin; Pharmorubicin; (8S,10S)-10-[(3-Amino-2,3,6-trideoxy-alpha-l-arabino-hexopyranosyl)oxy]-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride; 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-, hydrochloride (1:1), (8S,10S)-; 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S,10S)- (9CI); 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)- 结构式
Primary record

4'-Epidoxorubicin hydrochloride; 4'-epi-Adriamycin hydrochloride; Ellence; Epidoxorubicin hydrochloride; Epirubicin hydrochloride; Farmorubicin; Pharmorubicin; (8S,10S)-10-[(3-Amino-2,3,6-trideoxy-alpha-l-arabino-hexopyranosyl)oxy]-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride; 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-, hydrochloride (1:1), (8S,10S)-; 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S,10S)- (9CI); 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)-

库存
8,969 克
纯度
99.4 %
CAS
56390-09-1

化合物标识与属性

CAS
56390-09-1
PubChem CID
65348
SMILES
C[C@H]1[C@@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O.Cl
Canonical SMILES
COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1.Cl

名称与同义词

  • Epirubicin hydrochloride
  • Epirubicin HCl
  • Ellence
  • Pharmorubicin
  • Farmorubicin
  • Farmorubicina
  • 56390-09-1
  • Epirubitec
  • doxorubicin
  • Epirubicin Ebewe
  • Epidoxorubicin
  • Adriamycin
  • Pidorubicin
  • Pharmorubicin Pfs
  • 4'-epi-Adriamycin
  • Ellence (TN)
  • epi-Doxorubicin HCl
  • 4'-epi-Doxorubicin
  • Epidoxorubicin hydrochloride
  • IMI-28
  • epirubicin (hydrochloride)
  • Epirubiein Hydrochloride
  • E-ADM
  • RefChem:55118
  • Doxorubicin Hydrochloride
  • 4'-epi-DX
  • Hydrochloride, Epirubicin
  • 4'-Epidoxorubicin hydrochloride
  • CCRIS 4477
  • 4'-epi-Adriamycin hydrochloride
  • C27H30ClNO11
  • MFCD00941448
  • Epirubicin Hydrochloride RS
  • MLS001401404
  • SCHEMBL3165
  • Epirubicin hydrochloride CRS
  • IMI28
  • UNII-22966TX7J5
  • MLS000759412
  • 4-Epidoxorubicin hydrochloride
  • C27H29NO11.ClH
  • NSC-759195
  • DTXSID50860297
  • EINECS 260-145-2
  • EPIRUBICIN HCL [VANDF]
  • MWWSFMDVAYGXBV-FGBSZODSSA-N
  • WP-697
  • AC1L233G
  • orb1310913
  • 22966TX7J5
  • CHEMBL1200981
  • NSC 256942
  • SCHEMBL29379962
  • SCHEMBL30077487
  • ERK5-2O04
  • CHEBI:232543
  • Epirubicin hydrochloride [USAN:JAN]
  • C27H29NO11
  • DTXCID001475450
  • HY-13624AR
  • Pharmakon1600-01505708
  • AMY10308
  • CID65348
  • EX-A2654
  • C27-H29-N-O11.Cl-H
  • BBF-04657
  • EBC-17157
  • EPIRUBICIN HYDROCHLORIDE [MI]
  • HY-13624A
  • NSC759195
  • s1223
  • CPD000466308
  • Epirubicin HCl (4'-epidoxorubicin)?
  • Epirubicin hydrochloride (JP18/USP)
  • EPIRUBICIN HYDROCHLORIDE [JAN]
  • Epirubicin hydrochloride [USAN:USP:JAN]
  • SMR000466308
  • AKOS030526162
  • Epirubicin (hydrochloride) (Standard)
  • ACN-036868
  • BCP9000651
  • CCG-100950
  • CS-1773
  • EPIRUBICIN HYDROCHLORIDE [USAN]
  • FE22741
  • NC00200
  • 56390-09-1 (HCl)
  • EPIRUBICIN HYDROCHLORIDE [MART.]
  • EPIRUBICIN HYDROCHLORIDE [USP-RS]
  • EPIRUBICIN HYDROCHLORIDE [WHO-DD]
  • AS-75323
  • BC208841
  • LS-93989
  • SAM001246559
  • SY076232
  • (8S-cis)-4'-Epidoxorubicin Hydrochloride
  • Epirubicin hydrochloride, >=90% (HPLC)
  • E0840
  • NS00087126
  • EPIRUBICIN HYDROCHLORIDE [ORANGE BOOK]
  • A10345
  • D02214
  • D83113
  • EPIRUBICIN HYDROCHLORIDE [EP MONOGRAPH]
  • EPIRUBICIN HYDROCHLORIDE [USP MONOGRAPH]
  • 33811-EP2275420A1
  • 33811-EP2295055A2
  • 33811-EP2295416A2
  • 33811-EP2298748A2
  • 33811-EP2298764A1
  • 33811-EP2298765A1
  • 33811-EP2305642A2
  • 33811-EP2311453A1
  • Epirubicin hydrochloride, 98% - 100MG 100mg
  • A857961
  • F811935
  • SR-01000763557
  • (8S,10S)-10-(((2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride
  • SR-01000763557-3
  • Q27253634
  • (1S,3S)-3-Glycoloyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl 3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranoside hydrochloride
  • 5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)-
  • 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-, hydrochloride (1:1), (8S,10S)-
  • (7S,9S)-7-[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione hydrochloride
  • (7S,9S)-7-[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
  • (8S-cis)-10-((3-Amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione hydrochloride
  • 25316-40-9
  • 5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-arabinohexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S,10S)-
  • Epirubicin hydrochloride, British Pharmacopoeia (BP) Reference Standard
  • Epirubicin hydrochloride, European Pharmacopoeia (EP) Reference Standard
  • 5,12-naphthacenedione,10-((3-amino-2,3,6-trideoxy-alpha-l-arabino-hexopyranosy
  • Epirubicin hydrochloride, United States Pharmacopeia (USP) Reference Standard
  • (1S,3S)-3,5,12-Trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranoside--hydrogen chloride (1/1)
  • (1S,3S)-3-GLYCOLOYL-1,2,3,4,6,11-HEXAHYDRO-3,5,12-TRIHYDROXY-10-METHOXY-6,11-DIOXO-1-NAPHTHACENYL 3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-ARABINO-HEXOPYRANOSIDE HYDROCHLORIDE
  • (2S,4S)-4-(3-Amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyloxy)-2,5,12-trihydroxy-2-hydroxyacetyl-7-methoxy-1,2,3,4-tetrahydrotetracene-6,11-dione monohydrochloride
  • (7S,9S)-7-[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
  • (8S,10S)-10-(((2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dionehydrochloride
  • (8S,10S)-10-[(3-Amino-2,3,6-trideoxy-a-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-meth oxy-5,12-naphthacenedione hydrochloride
  • (8S,10S)-10-{[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione hydrochloride
  • (8S-cis)-10-((3-Amino-2,3,6-trideoxy-beta-L-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione Hydrochloride
  • (8S-cis)-10-[(3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione hydrochloride
  • 3-Glycoloyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl-3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranoside Hydrochloride
  • 4'-Epidoxorubicin hydrochloride; 4'-epi-Adriamycin hydrochloride; Ellence; Epidoxorubicin hydrochloride; Epirubicin hydrochloride; Farmorubicin; Pharmorubicin; (8S,10S)-10-[(3-Amino-2,3,6-trideoxy-alpha-l-arabino-hexopyranosyl)oxy]-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride; 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-, hydrochloride (1:1), (8S,10S)-; 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S,10S)- (9CI); 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)-
  • 5,?12-?Naphthacenedione, 10-?[(3-?amino-?2,?3,?6-?trideoxy-?|A-?L-?arabino-?hexopyranosyl)?oxy]?-?7,?8,?9,?10-?tetrahydro-?6,?8,?11-?trihydroxy-?8-?(2-?hydroxyacetyl)?-?1-?methoxy-?, hydrochloride (1:1)?, (8S,?10S)?-
  • 5,12-Naftacenediona, 10-[(3-amino-2,3,6-trideoxi alfa-L-arabino-hexopiranosil)] oxi-7,8,9,10-tetrahidro-6, 8,11-trihidroxi-8-(2-hidroxiacetil)-1-metoxi-,clorhidrato (1:1), (8S, 10S)-
  • 5,12-NAPHTHACENEDIONE, 10-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-ARABINO-HEXOPYRANOSYL)OXY)-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-8-(HYDROXYACETYL)-1-METHOXY-, HYDROCHLORIDE, (8S-CIS)-
  • 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S,10S)-
  • 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)-
  • 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-|_-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-, hydrochloride (1:1), (8S,10S)-
  • 56420-45-2
  • EPI